Mostafa ElSayed

Mostafa ElSayed, Co-founder and CEO of Automata, leads a pioneering company in lab automation, merging his architectural insights with robotics and AI. He discusses how Automata's LINQ platform enhances drug discovery workflows through integration and modularity. ElSayed envisions a future where AI-driven approaches replace traditional methods, increasing transparency in clinical candidates. He also emphasizes the importance of user feedback in product design, ensuring that innovation is driven by real scientific needs.